Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIVKU2 infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail
- 24 October 2007
- Vol. 370 (1) , 130-141
- https://doi.org/10.1016/j.virol.2007.08.022
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responsesBlood, 2006
- A Noninfectious Simian/Human Immunodeficiency Virus DNA Vaccine That Protects Macaques against AIDSJournal of Virology, 2005
- Cellular Immunity Elicited by Human Immunodeficiency Virus Type 1/ Simian Immunodeficiency Virus DNA Vaccination Does Not Augment the Sterile Protection Afforded by Passive Infusion of Neutralizing AntibodiesJournal of Virology, 2003
- HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signalingJournal of Leukocyte Biology, 2003
- Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytesNature, 2002
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- A Synthetic Peptide from the First Conserved Region in the Envelope Protein gp160 Is a Strong T-Cell Epitope in HIV-Infected Chimpanzees and HumansViral Immunology, 1998
- Induction of Human Immunodeficiency Virus-Specific T Cell Responses in Rhesus Monkeys by Synthetic Peptides from gp160AIDS Research and Human Retroviruses, 1993
- Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env proteinAIDS, 1991
- Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.The Journal of Experimental Medicine, 1990